Figure 5
From: Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy

Agonistic cMet Ab and rHGF protects human glomerular endothelial cells (GECs) against fibrosis in an in vitro model. (A–D) After fibrosis induction with TGF-β in GECs, agonistic cMet Ab (A,C) and rHGF (B,D) ameliorated the fibrosis. The cropped blots are used in the figure, and full-length blots are presented in Supplementary Figs S2–S3, respectively. All values are presented as the means ± SEM (n = 4 per group for each experiment). *P < 0.05, **P < 0.01.